CausalSentinel

Protein Dossier — PYY (Peptide YY)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: G47 Sleep disorders 0.593 0.121 9.10e-07 Wald ratio 1 cis NA
Fractured bone site(s): Arm 0.441 0.108 4.61e-05 Wald ratio 1 cis NA
Diagnoses - main ICD10: N81 Female genital prolapse 0.385 0.0946 4.74e-05 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypopituitarism 1.19 0.303 8.85e-05 Wald ratio 1 cis NA
Triglycerides 0.117 0.0318 2.33e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: emphysema or chronic bronchitis 0.362 0.1 3.14e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: gastro-oesophageal reflux (gord) or gastric reflux 0.216 0.0642 7.72e-04 Wald ratio 1 cis NA
Putamen volume -117 40.8 0.00412 Wald ratio 1 cis NA
HDL cholesterol -0.0904 0.0325 0.00536 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoarthritis 0.132 0.0484 0.00624 Wald ratio 1 cis NA
Fasting glucose 0.0522 0.0204 0.0104 Wald ratio 1 cis NA
Age at menopause 0.318 0.127 0.0124 Wald ratio 1 cis NA
…and 97 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3727_35_1 PYY Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

19 association rows across 17 traits (13 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
PYY protein levels 1e-249 rs8074783 2 GCST90470398 no MR -> candidate analysis
Hematological traits (multi-trait analysis) 9e-38 rs573345854 2 GCST90838669 no MR -> candidate analysis
CD300LG protein levels 3e-21 rs1642598 1 GCST90468623 no MR -> candidate analysis
HDL levels x fish oil supplementation interaction (2df) 3e-16 rs147438979 1 GCST011927 no MR -> candidate analysis
Triglyceride levels 1e-15 rs116878033 1 GCST010244 no MR -> candidate analysis
Serum levels of protein PYY 2e-14 rs2341378 1 GCST90088497 no MR -> candidate analysis
Metabolic syndrome cluster 4 (lipodystrophy-like endotype) 4e-10 rs147438979 1 GCST90859211 no MR -> candidate analysis
Blood protein levels 1e-9 rs8074783 1 GCST006585 no MR -> candidate analysis
Total body bone mineral density 2e-9 rs116953263 1 GCST005348 no MR -> candidate analysis
DNA methylation variation (age effect) 3e-8 rs4793062 1 GCST006660 no MR -> candidate analysis
Pulse pressure 4e-8 rs62080325 1 GCST004278 no MR -> candidate analysis
Omega-6 fatty acid percentage of total fatty acids 5e-8 rs116878033 1 GCST90454484 no MR -> candidate analysis
…and 5 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 551 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hyperammonemia due to N-acetylglutamate synthase deficiency 0.532 established (curated) no MR -> candidate analysis
Hyperammonemia due to N-acetylglutamate synthetase deficiency 0.532 established (curated) no MR -> candidate analysis
Obesity 0.182 established (curated) MR: beta=0.729, p=0.0501 (cis)

Of the 3 rows above, 2 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=1.9e-05, LOEUF=1.89 — LoF-tolerant
GWAS Catalog 62 unique SNPs / 124 rows
ClinVar 58 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance